Compare Ross Stores, Inc. (ROST) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ross Stores, Inc. vs Sana Biotechnology Inc — how do they compare? Ross Stores, Inc. trades at $222.41 (market cap $71.94B), while Sana Biotechnology Inc trades at $2.79 (market cap $836.71M). The key difference: Ross Stores, Inc. is far larger — about 86× Sana Biotechnology Inc's market cap, and Ross Stores, Inc. pays a 0.79% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ross Stores, Inc. for 48 Days and Sana Biotechnology Inc for 23 Days on average.
| ROST | SANA | |
|---|---|---|
Market Cap | $71.94B | $836.71M |
Volume | 2,002,519 | 4,507,444 |
Sector | Consumer Cyclical | Health |
52-Week High | $255.23 | $5.92 |
52-Week Low | $147.71 | $2.68 |
Typical Hold Time | 48 Days | 23 Days |
Enterprise Value | $72.39B | $749.96M |
Dividend Yield | 0.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ross Stores (ROST) trades at $225.2, down 0.15% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.66 surpassing the $1.95 forecast. Revenue grew to $21.13B in 2025, and net income margin improved to 10.85%. Analyst consensus is bullish with a $274.14 price target, though technical indicators show resistance near $226.
The outlook for ROST is positive due to robust earnings performance, store expansion initiatives, and strong profitability metrics like a 42.63% ROE. Risks include competitive pressures and rising costs, but institutional buying and a high analyst buy rating (63.83%) support upside potential. The stock presents a compelling opportunity for growth investors seeking value in the discount retail sector.
SANA Biotechnology trades at $2.79, up 2.57% today, but faces significant fundamental challenges with negative revenue, substantial losses, and bearish technical indicators. The company reported a net loss of $244.17 million in 2025 with no revenue, while technical analysis shows a bearish trend with moving averages and ADX indicators signaling selling pressure. Recent news highlights multiple investor conference presentations and ongoing legal scrutiny regarding fiduciary duties.
Despite strong analyst support (82% buy ratings), SANA's lack of revenue generation and negative profitability metrics present substantial investment risk. The company's cash flow remains negative, requiring continued financing. Near-term catalysts include upcoming Q3 earnings and clinical developments, but investors should weigh the high-risk profile against potential long-term biotechnology breakthroughs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
